Thrivent Financial for Lutherans
CC icon

Thrivent Financial for Lutherans’s Chemours CC Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.2M Sell
100,049
-2,947
-3% -$51.3K ﹤0.01% 1367
2025
Q4 		$1.21M Sell
102,996
-5,001
-5% -$64.2K ﹤0.01% 1808
2025
Q3 		$1.71M Sell
107,997
-113,927
-51% -$1.65M ﹤0.01% 1440
2025
Q2 		$2.54M Sell
221,924
-8,579
-4% -$96.7K 0.01% 1193
2025
Q1 		$3.12M Buy
230,503
+49,002
+27% +$814K 0.01% 1029
2024
Q4 		$3.07M Sell
181,501
-63,086
-26% -$1.23M 0.01% 1159
2024
Q3 		$4.97M Sell
244,587
-1,001
-0.4% -$20.5K 0.01% 927
2024
Q2 		$5.54M Buy
245,588
+20,187
+9% +$529K 0.01% 854
2024
Q1 		$5.92M Buy
225,401
+188,319
+508% +$5.37M 0.01% 823
2023
Q4 		$1.17M Buy
37,082
+5
+0% +$136 ﹤0.01% 1738
2023
Q3 		$1.04M Sell
37,077
-1,422
-4% -$48.8K ﹤0.01% 1718
2023
Q2 		$1.42M Sell
38,499
-648
-2% -$19.8K ﹤0.01% 1567
2023
Q1 		$1.17M Sell
39,147
-1,052
-3% -$34.7K ﹤0.01% 1683
2022
Q4 		$1.23M Sell
40,199
-24,876
-38% -$746K ﹤0.01% 1594
2022
Q3 		$1.6M Buy
65,075
+24,287
+60% +$801K ﹤0.01% 1362
2022
Q2 		$1.31M Sell
40,788
-127,948
-76% -$4.71M ﹤0.01% 1529
2022
Q1 		$5.31M Sell
168,736
-96,460
-36% -$3.02M 0.01% 867
2021
Q4 		$8.9M Buy
265,196
+81,364
+44% +$2.53M 0.02% 712
2021
Q3 		$5.34M Sell
183,832
-1,661
-0.9% -$53.8K 0.01% 863
2021
Q2 		$6.46M Sell
185,493
-219
-0.1% -$7.25K 0.01% 821
2021
Q1 		$5.18M Sell
185,712
-70,106
-27% -$1.87M 0.01% 903
2020
Q4 		$6.34M Buy
255,818
+246
+0.1% +$5.85K 0.01% 787
2020
Q3 		$5.34M Sell
255,572
-26,456
-9% -$511K 0.01% 773
2020
Q2 		$4.33M Buy
282,028
+2,642
+0.9% +$33.4K 0.01% 752
2020
Q1 		$2.48M Buy
279,386
+236,664
+554% +$3.41M 0.01% 859
2019
Q4 		$773K Buy
42,722
+276
+0.7% +$4.58K ﹤0.01% 1629
2019
Q3 		$634K Sell
42,446
-423,260
-91% -$6.89M ﹤0.01% 1694
2019
Q2 		$11.2M Buy
465,706
+43,125
+10% +$1.27M 0.03% 482
2019
Q1 		$15.7M Buy
422,581
+21,288
+5% +$775K 0.05% 369
2018
Q4 		$11.3M Buy
401,293
+358,372
+835% +$11.3M 0.04% 411
2018
Q3 		$1.69M Buy
42,921
+2,385
+6% +$104K 0.01% 971
2018
Q2 		$1.8M Sell
40,536
-1,863
-4% -$92.7K 0.01% 955
2018
Q1 		$2.06M Sell
42,399
-147,105
-78% -$7.35M 0.01% 887
2017
Q4 		$9.49M Buy
189,504
+9,930
+6% +$520K 0.03% 473
2017
Q3 		$9.09M Buy
179,574
+142,384
+383% +$6.72M 0.03% 465
2017
Q2 		$1.41M Buy
37,190
+2,990
+9% +$118K 0.01% 959
2017
Q1 		$1.32M Sell
34,200
-63,030
-65% -$1.9M 0.01% 1027
2016
Q4 		$2.15M Buy
97,230
+4,470
+5% +$91.8K 0.01% 833
2016
Q3 		$1.48M Buy
92,760
+3,840
+4% +$43.9K 0.01% 975
2016
Q2 		$732K Buy
88,920
+1,480
+2% +$13.2K ﹤0.01% 1242
2016
Q1 		$612K Buy
87,440
+65,840
+305% +$331K ﹤0.01% 1281
2015
Q4 		$116K Buy
21,600
+1,450
+7% +$9.27K ﹤0.01% 1819
2015
Q3 		$130K Buy
+20,150
New +$211K ﹤0.01% 1678

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Thrivent Financial for Lutherans's CC Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Chemours (CC) stake by 2.9% in Q1 2026, selling an estimated $51.3K and leaving 100,049 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Thrivent Financial for Lutherans first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $15.7M in Q1 2019. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Thrivent Financial for Lutherans held 100,049 shares of Chemours worth $2.2M as of Q1 2026.
  • Thrivent Financial for Lutherans sold 2,947 Chemours shares in Q1 2026, an estimated $51.3K.
  • Chemours made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1367 holding.
  • Thrivent Financial for Lutherans first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • Thrivent Financial for Lutherans's Chemours position peaked at $15.7M in Q1 2019.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.